1. Drugs in Human Milk Part 1: Practical and Analytical Considerations in Measuring Drugs and Metabolites in Human Milk

   • Osama Y. Alshogran
   • Prerna Dodeja
   • Raman Venkataramanan

   Review Article 15 May 2024 Pages: 561 - 588

   

2. Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature Review

   • J. van Gendt
   • R. Emaus
   • Paola Mian

   Systematic Review Open access 07 April 2024 Pages: 589 - 622

   

3. Population Pharmacokinetics of Intravenous Lidocaine in Adults: A Systematic Review

   • Keng Wah Foong
   • Sook Hui Chaw
   • Pui San Loh

   Systematic Review 04 May 2024 Pages: 623 - 643

   

4. Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

   • Anouk M. E. Jansen
   • Kim Snijdelaar
   • Rob ter Heine

   Original Research Article Open access 26 March 2024 Pages: 645 - 656

   

5. Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling

   • Krina Mehta
   • Pavel Balazki
   • J. G. Coen van Hasselt

   Original Research Article Open access 26 March 2024 Pages: 657 - 668

   

6. Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors

   • Abhishek G. Sathe
   • Indrajeet Singh
   • Ahmed A. Othman

   Original Research Article Open access 05 April 2024 Pages: 669 - 681

   

7. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

   • Julia E. M. van Dommelen
   • Heleen Grootjans
   • Maaike A. Sikma

   Original Research Article Open access 06 April 2024 Pages: 683 - 693

   

8. Time-Varying Clearance in Milrinone Pharmacokinetics from Premature Neonates to Adolescents

   • Conor J. O’Hanlon
   • Anita Sumpter
   • Jacqueline A. Hannam

   Original Research Article Open access 13 April 2024 Pages: 695 - 706

   

9. Development of a Weight-Band Dosing Approach for Vosoritide in Children with Achondroplasia Using a Population Pharmacokinetic Model

   • Yulan Qi
   • Ming Liang Chan
   • Joshua Henshaw

   Original Research Article Open access 23 April 2024 Pages: 707 - 719

   

10. Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers

    • Lisanne A. H. Bevers
    • Anne E. M. Kamphuis
    • Angela Colbers

    Original Research Article Open access 04 April 2024 Pages: 721 - 728

    

11. Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers

    • Lisanne A. H. Bevers
    • Anne E. M. Kamphuis
    • Angela Colbers

    Correction Open access 02 May 2024 Pages: 729 - 730

12. Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”

    • Leping Kong
    • Jan-Willem C. Alffenaar
    • Sophie L. Stocker

    Letter to the Editor 04 April 2024 Pages: 731 - 733